Given the link between TIMP-1 and enhanced immunogenicity in melanoma, its interaction with CD74 might either bolster its MHC-I/II chaperoning role or compete with MIF, reducing MIF-induced suppressive effects through CD74. Here, TIMP1 is linked to melanoma.